The global hepatitis C virus (HCV) testing market is poised for significant growth, with its market size expected to accumulate a value of USD 785.3 million by the end of 2023. Over the forecast period from 2023 to 2033, the market is projected to expand at a compound annual growth rate (CAGR) of 5.4%, reaching an estimated value of USD 1,326.7 million by 2033.
From 2018 to 2022, the HCV testing market grew at a CAGR of 4.6%, driven by increasing awareness of hepatitis C, rising government initiatives for early diagnosis, and advancements in testing technologies. The demand for accurate and early diagnosis of HCV infections is rising globally as healthcare providers and patients prioritize preventive measures and timely treatment.
The steady increase in the global incidence of hepatitis C, coupled with technological advancements in testing, is expected to further boost the market’s growth over the next decade. HCV testing continues to play a critical role in managing and controlling the spread of this potentially life-threatening disease.
As per recent guidelines for hepatitis C screening by Centers for Disease control and Prevention (CDC), cut-off ratio for anti HPV antibodies is added which helps to decide additional assays for confirmation of screening results. Nucleic acid amplification test (NAT) is used as a confirmatory test and to determine viral load. All positive antibody tests are followed by RNA test. Genotyping tests for HCV are used in clinical management of HPV to determine viral load and optimal duration of treatment. Long term Use of injection drugs, use of non-sterile needles for tattooing and body piercing etc. are common causes for spread of hepatitis C virus infection.
Hepatitis C Virus (HCV) Testing Market: Drivers and Restraints
Growing incidence of hepatitis C virus infection is the major factor driving growth of global hepatitis C virus testing market. Inappropriate practices of blood donation is the major cause for spread of hepatitis C virus infection. Hepatitis C screening is the mandatory screening test prior to organ donation, and growing organ donation programs across the globe is expected to push the market growth. Launch of point of care testing products for HCV testing increases demand for HCV testing kits. In 2010, OraQuick HCV Rapid Antibody Test was approved by FDA which is now largely being used as an alternative to enzyme immunoassay testing for HCV. Application of new electrochemical immunosensor and genosensor technologies in HPV testing are expected to change conventional HPV testing practices. However, inadequate insurance coverage for hepatitis C testing and limited access to regular health care are the factors restraining the growth of global hepatitis C virus testing market.
Hepatitis C Virus (HCV) Testing Market: Overview
Prevalence of hepatitis C is low when compared to hepatitis A and hepatitis B. Thus little efforts are being taken to develop novel tests for hepatitis C virus testing. Among all 3 test types, HCV antibody testing is expected to take highest share in global hepatitis C virus testing market, as antibody testing is the primary screening test for HCV testing and large population undergo routine HCV antibody testing. Among end users, diagnostic centers end user segment is expected to contribute highest market share in global HCV testing market.
Hepatitis C Virus (HCV) Testing Market: Regional Outlook
Geographically, hepatitis C virus testing market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Western Europe is expected to dominate global hepatitis C virus testing market over the forecast period due to high incidence of HCV. Asia Pacific is expected to be the second largest market for HCV testing. According to WHO, Eastern Mediterranean and European region have the highest prevalence of HCV with the prevalence of 2.3% and 1.5%, respectively. HCV virus shows significant genetic variations in global population due to high rate of viral RNA mutation.
Hepatitis C Virus (HCV) Testing Market: Key Players
Some of the players identified in global hepatitis C virus testing market include OraSure Technologies, Inc., Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Ortho Clinical Diagnostic Inc. (Johnson & Johnson), Bayer AG, QIAGEN N.V., Thermo Fisher Scientific Inc., BioGenex, AccuQuick, Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits etc. among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Hepatitis C Virus (HCV) Testing Market: Segmentation
Tentatively, global hepatitis C virus testing market has been segmented on the basis of test type, technique, end user, and geography.
Based on technique, global hepatitis C virus testing market is segmented as below:
- Immunoassays
- Polymerase Chain Reaction (PCR)
- Others
Based on test type, global hepatitis C virus testing market is segmented as below:
- HCV Antibody Tests
- HCV Viral Load Tests
- HCV Genotyping Tests
Based on end user, global hepatitis C virus testing market is segmented as below:
- Hospitals
- Diagnostic Centers
- Blood Donation Centers
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
